SF: This would be the biggest loss, as they cost a lot more than a vaccine shot. The list price for Eli Lilly’s bebtelovimab, which last month launched in the commercial market, is $2,100 per dose. People with Medicare might still be able to afford them because they are often given in a hospital or outpatient setting, but they could be out of reach for the uninsured and even those with private insurance might decide they are too expensive. Sadly, antibodies could be the best way to manage the effects of waves of infections, especially in the more vulnerable populations.
Jay Alexander james is a prolific News and Content marketer.Based Leeds United kingdom Jay Has vastly contributed to the Upliftment of the news Standards in United Kingdom